Novartis Ag (NVSEF) EBIT (QoQ) (2009 - 2023)

Novartis Ag (NVSEF) EBIT (QoQ) (2009 - 2023) Analysis & Trends

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Eli Lilly	1,066.16 Bn	1,060.88 Bn	16.22 Bn
2	Johnson & Johnson	611.69 Bn	589.64 Bn	15.96 Bn
3	AbbVie	444.34 Bn	434.99 Bn	10.78 Bn
4	Astrazeneca	284.94 Bn	277.05 Bn	12.61 Bn
5	Merck	224.23 Bn	218.58 Bn	12.09 Bn
6	Amgen	195.12 Bn	183.08 Bn	5.87 Bn
7	Gilead Sciences	156.45 Bn	148.73 Bn	5.52 Bn
8	Pfizer	136.01 Bn	123.24 Bn	-1.21 Bn
9	Novartis Ag	113.45 Bn	113.67 Bn	-
10	Novartis Ag	-	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2023	-99.94%
Mar 31, 2023	26,105.32%
Dec 31, 2022	2,735.51%
Sep 30, 2022	-95.63%
Jun 30, 2022	1,941.46%
Mar 31, 2022	-8.15%
Dec 31, 2021	13.38%
Sep 30, 2021	-95.33%
Jun 30, 2021	-99.89%
Mar 31, 2021	77,673.11%
Dec 31, 2020	2,393.35%
Sep 30, 2020	-69.30%
Jun 30, 2020	5,326.67%
Jun 30, 2019	875.46%
Mar 31, 2019	-85.08%
Dec 31, 2018	27.53%
Sep 30, 2018	-42.23%
Jun 30, 2018	507.33%
Mar 31, 2018	-75.29%
Dec 31, 2017	-0.72%